Loading

Expanding horizons for CGT in autoimmune and neurological conditions

12 Feb 2026
Theatre 1
Technology and Innovation

Examine the potential of CGT to treat autoimmune and neurological disorders. Participants will gain insights into identifying suitable targets, designing interventions, and navigating translational challenges to broaden the clinical impact of advanced therapies.

 

Key takeaways:

  • Learn approaches to apply CGT in autoimmune and neurological indications.
  • Explore strategies for target selection and therapeutic design.
  • Apply insights to overcome translational and clinical development challenges.
  • Understand considerations for safety, efficacy, and patient selection.
  • Gain perspectives on expanding the reach of CGT beyond traditional indications.